Article thumbnail

Antivenomics of Atropoides mexicanus and Atropoides picadoi snake venoms: Relationship to the neutralization of toxic and enzymatic activities

By José Antúnez, Julián Fernández, Bruno Lomonte, Yamileth Angulo, Libia Sanz, Alicia Pérez, Juan José Calvete and José María Gutiérrez


Viperid snakes of the genus Atropoides are distributed in Mexico and Central America and, owing to their size and venom yield, are capable of provoking severe envenomings in humans. This study evaluated, using an ‘antivenomics’ approach, the ability of a polyspecific (polyvalent) antivenom manufactured in Costa Rica to recognize the proteins of Atropoides mexicanus and A. picadoi venoms, which are not included in the immunization mixture. In addition, the neutralization of lethal, hemorrhagic, myotoxic, coagulant, proteinase and phospholipase A2 (PLA2) activities of these venoms by the antivenom was assessed. The antivenom was highly-effective in immunodepleting many venom components, particularly high molecular mass P-III metalloproteinases (SVMPs), L-amino acid oxidases, and some serine proteinases and P-I SVMPs. In contrast, PLA2s, certain serine proteinases and P-I SVMPs, and a C type lectin-like protein were only partially immunodepleted, and two PLA2 molecules were not depleted at all. The antivenom was able to neutralize all toxic and enzymatic activities tested, although neutralization of lethality by A. nummifer venom was achieved when a challenge dose of 3 LD50s of venom was used, but was iffective when 4 LD50s were used. These results, and previously obtained evidence on the immunoreactivity of this antivenom towards homologous and heterologous venoms, revealed the low immunogenicity of a number of venom components (PLA2s, CRISPs, P-I SVMPs, and some serine proteinases), underscoring the need to search for innovative immunization protocols to improve the immune response to these antigens

Topics: Research Article
Publisher: Library Publishing Media
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2004). A novel P-I class metalloproteinase with broad substrate-cleaving activity, agkislysin, from Agkistrodon acutus venom.
  2. (1992). An electrophoretic study on phospholipase A 2 isoenzymes in the venoms of Central American crotaline snakes.
  3. (1994). Caprylic acid fractionation of hyperimmune horse plasma: description of a simple procedure for antivenom production.
  4. (1986). Characterization of venoms and standardization of antivenoms. In: Harris,
  5. (1997). Clinical and laboratory alterations in horses during immunization with snake venoms for the production of polyvalent (Crotalinae)
  6. (2008). Determinación de Actividades Tóxicas de Venenos de Serpientes y su Neutralización por Antivenenos. Manual de Métodos de Laboratorio. Instituto Clodomiro Picado,
  7. (1983). Development of simple standard assay procedures for the characterization of snake venoms.
  8. (1979). Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.
  9. (2002). Geographic and ontogenic variability in the venom of the neotropical rattlesnake Crotalus durissus : pathophysiological and therapeutic implications.
  10. (2010). Impact of regional variation in Bothrops asper snake venom on the design of antivenoms: integrating antivenomics and neutralization approaches.
  11. (1987). Neutralización de las actividades tóxicas y enzimáticas de cuatro venenos de serpientes de Guatemala y Honduras por el antiveneno polivalente producido en Costa Rica.
  12. (2000). Neutralization of crotaline snake venoms form Central and South America by antivenoms produced in
  13. (2010). Preclinical assessment of the neutralizing capacity of antivenoms produced in six Latin American countries against medically-relevant Bothrops snake venoms. Toxicon,
  14. (1981). Progress in the Characterization of Venoms and Standardization of Antivenoms. World Health Organization,
  15. (2003). Report of a WHO workshop on the standardization and control of antivenoms.
  16. (2009). Snake venom metalloproteinases. Biological roles and participation in the pathophysiology of envenomation. In:
  17. (2008). Snake Venomics and Antivenomics of the Arboreal Neotropical Pitvipers Bothriechis lateralis and Bothriechis schlegelii .
  18. (2009). Snake venomics and antivenomics: proteomic tools in the design and control of antivenoms for the treatment of snakebite envenoming.
  19. (2008). Snake venomics of Central American pitvipers. Clues for rationalizing the distinct envenomation profi les of Atropoides nummifer and Atropoides picadoi .
  20. (2008). Snake venomics of the lancehead pitviper Bothrops asper : geographic, individual and ontogenetic variations.
  21. (2008). Snake venomics of the Lesser Antillean pit vipers Bothrops caribbaeus and Bothrops lanceolatus : correlation with toxicological activities and immunoreactivity of a heterologous antivenom.
  22. (2009). Snakebite envenomation in Central America. In:
  23. (2001). The venom of Bothrops asper from Guatemala: toxic activities and neutralization by antivenoms.